It’s considering changes to its annual stress test.
One tax expert says the drug giant is vastly exaggerating its eventual tax rate.
The nation’s largest public pension system shares a big number that is actually kind of small.
The on-demand workforce expects a la carte products and services.
Amid questions about the company’s future.
He’s now the second-largest shareholder.
Here’s what you need to know today.
The gap between Pfizer’s offer and Allergan’s stock price suggests investors are skeptical about the deal.